Core Trading Co

Core Trading Co Inc., a service-disabled veteran-owned and minority-owned small business headquartered in Chesapeake, Virginia, supplies pharmaceuticals and medical-surgical commodities to federal healthcare agencies as a prime contractor operating exclusively in full-and-open and total small business set-aside categories. The company is a Subchapter S Corporation, self-certified as small disadvantaged, and holds SDVOSB and VOSB credentials across its recent contracting footprint.

Core Trading Co's federal work centers on pharmaceutical and medical supply distribution to VA Consolidated Mail Outpatient Pharmacies (CMOPs) and the Defense Logistics Agency Medical Supply Chain. The vendor's concrete capability set spans prescription pharmaceuticals (carboxymethylcellulose sodium ophthalmic solutions, budesonide inhalation suspension, guaifenesin liquid, fenofibrate, acetaminophen combinations, cefdinir capsules, moxifloxacin hydrochloride, albuterol sulfate); over-the-counter medical supplies (eyelid cleansers, gauze pads, bandages, anesthesia sets, urinary drainage bags, glucose test strips, lancets, syringe gauges, patient monitoring cables, clinical thermometers); and specialized medical devices (intravenous stands, blood monitoring kits, otoscopes, ophthalmoscopes, defibrillator cases, tourniquets). Representative work includes a $822.5 thousand purchase order from Veterans Integrated Service Network 15 in March 2026 for carboxymethylcellulose sodium 1% ophthalmic gel with monthly deliveries through June 2026; a $557.7 thousand order from VISN 15 in February 2025 for budesonide inhalation suspension to multiple VA CMOPs; a $173.5 thousand award from VISN 15 in August 2024 for medical-surgical items including insulin pump reservoirs, reusable leg bags, lancets, and infusion sets; and recurring purchases of witch hazel pads, abdominal pads, and examination gloves from the DLA Medical Supply Chain ranging from hundreds to tens of thousands of dollars.

Customer concentration aligns heavily with the Department of Veterans Affairs healthcare system. The top five customer agencies by award count account for 83% of recent awards. Veterans Integrated Service Network 15 dominates both award volume (72 awards) and dollar value ($3.8 million combined potential value). The DLA Medical Supply Chain leads in award count (91 awards) but carries minimal dollar value ($102 thousand), reflecting high-velocity, low-dollar purchase orders for consumable supplies. Other significant VA networks include VISN 22 ($935 thousand), VISN 7 ($1 million), VISN 1 ($1.5 million), and VISN 12 ($1 million). Notably, the Tennessee National Guard awarded a $53.5 thousand order in July 2023 for MMR II and VARIVAX vaccine live injections, and the vendor has engaged with multiple other VISNs sporadically. The portfolio reflects concentration risk: 89% of combined potential value flows to five VA networks plus the DLA.

Core Trading Co operates exclusively as a prime contractor — all 312 awards in the recent portfolio are prime contracts, with zero subcontract engagement. The company does not hold seats on government-wide IDIQs, GWACs, or agency-wide vehicles; instead, it competes for task orders and purchase orders issued directly by individual VA networks, DLA Medical Supply Chain, and other agencies. Awards are almost entirely purchase orders with short performance cycles (typically 10-30 days from award to delivery) and ceiling values ranging from under $100 to approximately $850 thousand. Set-aside posture splits between full-and-open and total small business designations; the vendor also holds Service-Disabled Veteran-Owned Small Business set-aside certifications evident on roughly 15-20 awards in the portfolio.

Activity has accelerated sharply. The vendor recorded 14 awards in 2022, 40 in 2023, 27 in 2024, 19 in 2025, and 50 through mid-2026, indicating seasonal or volume-driven growth in recent months. Combined potential value sits at $9.2 million with $8.9 million obligated (98% execution rate), suggesting minimal pipeline and rapid cash-collection cadence. Award taxonomy concentrates in Pharmaceutical Preparation Manufacturing (200 awards) and Medical-Surgical Instruments and Supplies (81 awards by PSC), with residual exposure to in-vitro diagnostics and surgical appliances. All awards are purchase orders; the vendor has no IDVs, BPAs, or blanket agreements in the source. Recompete risk is minimal given the short-cycle purchase-order model, though loss of access to high-volume VA networks — particularly VISN 15 — would materially impact revenue. The vendor's footprint is typical of a medical-supply distributor serving federal healthcare systems via commodity procurement channels rather than larger systems-integration or service-delivery vehicles.

over 19 years of experience in Pharmaceutical wholesale industry, Procurement, Manage National Accounts, Sales Training, Budget